Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Germany Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20061
20071
20094
20101
20112
20121
20134
20141
20151
20175
20185
20192
20203
20215
20236
20249
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting15
Unknown status7
Active, not recruiting4
Terminated2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Merck Sharp & Dohme LLC6
Charite University, Berlin, Germany5
AGO Study Group3
University Hospital Tuebingen3
AstraZeneca2
Daiichi Sankyo2
European Organisation for Research and Treatment of Cancer - EORTC2
Ruhr University of Bochum2
Seagen, a wholly owned subsidiary of Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms59
Endometrial Neoplasms14
Ovarian Neoplasms11
Papillomavirus Infections7
Head and Neck Neoplasms6
Pancreatic Neoplasms6
Esophageal Neoplasms5
Recurrence5
Squamous Cell Carcinoma of Head and Neck5
Breast Neoplasms4

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.